NCT02928159View on ClinicalTrials.gov

Low Pulse Amplitude Seizure Therapy (LAP-ST Study)

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Mood DisordersSchizophrenia Spectrum and Other Psychotic Disorders
Interventions
DEVICE

Mecta spectrum 5000Q device

LAP-ST and Right Unilateral (RUL) electrode placement.

All Listed Sponsors
lead

Behman Hospital

OTHER

NCT02928159 - Low Pulse Amplitude Seizure Therapy (LAP-ST Study) | Biotech Hunter | Biotech Hunter